Weight gain and cardiovascular risk after organ transplantation.
Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication in other organ recipients. A number of factors explain this trend, including a high incidence of hypertension, posttransplant diabetes, hyperlipidemia, and obesity-risk factors that are mediated by direct effects of immunosuppressive medications. Weight gain posttransplant affects approximately 50% of patients and represents a significant problem because of the potential synergism between obesity and immunosuppressive medication-induced effects on cardiovascular disease risk factor development. This review discusses the incidence and implications of cardiovascular disease risk factors in organ transplant recipients, strategies for clinical management, and future research directions.
Baum
C L
CL
Department of Medicine, University of Illinois at Chicago, 60612, USA. baum@uic.edu
D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control; D048909:Diabetes Complications; D018565:Food-Drug Interactions; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D009765:Obesity / Q000150:complications; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D015430:Weight Gain
D007166:Immunosuppressive Agents